Chen Ren

1.9k total citations
73 papers, 1.4k citations indexed

About

Chen Ren is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chen Ren has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Chen Ren's work include Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Hepatitis B Virus Studies (5 papers). Chen Ren is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Hepatitis B Virus Studies (5 papers). Chen Ren collaborates with scholars based in China, United States and Taiwan. Chen Ren's co-authors include Shasha Du, Michael A. Freitas, Guozhu Xie, Kenneth K. Chan, Qiwei Yao, Manoj Maniar, Yawei Yuan, Xiaodan Su, François Wilhelm and Guixiang Liao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Chen Ren

66 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Ren China 24 717 276 267 207 140 73 1.4k
Luca Beltrame Italy 22 947 1.3× 385 1.4× 548 2.1× 259 1.3× 123 0.9× 57 2.1k
Feng Qi China 22 814 1.1× 242 0.9× 472 1.8× 192 0.9× 164 1.2× 74 1.4k
Nassim Ghaffari‐Tabrizi‐Wizsy Austria 23 968 1.4× 283 1.0× 309 1.2× 75 0.4× 73 0.5× 58 2.1k
Douglas C. Marchion United States 23 1.8k 2.5× 609 2.2× 253 0.9× 155 0.7× 143 1.0× 66 2.3k
Weiwei Li China 21 959 1.3× 218 0.8× 380 1.4× 135 0.7× 66 0.5× 72 1.5k
Lingling Liu China 22 645 0.9× 267 1.0× 238 0.9× 112 0.5× 128 0.9× 83 1.3k
Kyunggon Kim South Korea 24 961 1.3× 143 0.5× 155 0.6× 127 0.6× 109 0.8× 94 1.6k
Hideto Senzaki Japan 19 533 0.7× 224 0.8× 168 0.6× 159 0.8× 113 0.8× 64 1.3k

Countries citing papers authored by Chen Ren

Since Specialization
Citations

This map shows the geographic impact of Chen Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Ren more than expected).

Fields of papers citing papers by Chen Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Ren. The network helps show where Chen Ren may publish in the future.

Co-authorship network of co-authors of Chen Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Ren. A scholar is included among the top collaborators of Chen Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Ren. Chen Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Wenqing, Qinghua Zhang, Dafei Xie, et al.. (2025). GDF15 Drives Glioblastoma Radioresistance by Inhibiting Ferroptosis and Remodeling the Immune Microenvironment. International Journal of Biological Sciences. 21(15). 6794–6807.
2.
Chen, Chen, Wenqing Feng, Lei Yuan, et al.. (2025). Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy. Journal of Cancer Research and Clinical Oncology. 151(3). 112–112.
3.
Zhang, Wan, et al.. (2024). NLRP3 promotes radiation‐induced brain injury by regulating microglial pyroptosis. Neuropathology and Applied Neurobiology. 50(3). e12992–e12992. 6 indexed citations
4.
Zeng, Yingying, et al.. (2022). Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma. Frontiers in Genetics. 13. 795844–795844. 12 indexed citations
5.
Zhang, Dongjing, et al.. (2021). Current status of the treatment of chronic hepatitis B. 37(5). 1011–1015.
6.
7.
8.
Ren, Chen, Xiaohai Li, Bin He, & Wei Hu. (2017). MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma. Molecular Medicine Reports. 15(3). 1326–1334. 44 indexed citations
9.
Chen, Wenli, et al.. (2016). [The same disease with different syndromes: a proteomic study of chronic hepatitis B].. PubMed. 36(3). 410–3.
10.
Yao, Qiwei, Rong Zheng, Guozhu Xie, et al.. (2015). Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy. Scientific Reports. 5(1). 9119–9119. 9 indexed citations
11.
Bowles, Daniel W., Jennifer R. Diamond, Elaine T. Lam, et al.. (2014). Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies. Clinical Cancer Research. 20(6). 1656–1665. 54 indexed citations
12.
Yang, Chen, et al.. (2014). Localization of prestin and expression in the early period after radiation in mice. European Archives of Oto-Rhino-Laryngology. 271(12). 3333–3340. 7 indexed citations
13.
Wee, Wen, Wells A. Messersmith, Grace K. Dy, et al.. (2012). Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer. Clinical Cancer Research. 18(7). 2048–2055. 42 indexed citations
14.
Wang, Liwen, Sean W. Harshman, Shujun Liu, et al.. (2010). Assaying pharmacodynamic endpoints with targeted therapy: Flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia. PROTEOMICS. 10(23). 4281–4292. 13 indexed citations
15.
Guglin, Maya, Gregory Hartlage, C. Reynolds, Chen Ren, & Vinod F. Patel. (2009). Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study. Journal of Cardiac Failure. 15(8). 651–657. 61 indexed citations
16.
Liu, Zhongfa, Patty Fan‐Havard, Zhiliang Xie, Chen Ren, & Kenneth K. Chan. (2007). A liquid chromatography/atmospheric pressure ionization tandem mass spectrometry quantitation method for nevirapine and its two oxidative metabolites, 2‐hydroxynevirapine and nevirapine 4‐carboxylic acid, and pharmacokinetics in baboons. Rapid Communications in Mass Spectrometry. 21(16). 2734–2742. 9 indexed citations
17.
Su, Xiaodan, Naduparambil K. Jacob, Ravindra Amunugama, et al.. (2007). Liquid chromatography mass spectrometry profiling of histones. Journal of Chromatography B. 850(1-2). 440–454. 28 indexed citations
18.
Tu, Shengjiang, Esther M. M. Bulloch, Lanhao Yang, et al.. (2007). Identification of Histone Demethylases in Saccharomyces cerevisiae. Journal of Biological Chemistry. 282(19). 14262–14271. 90 indexed citations
19.
Su, Xiaodan, Chen Ren, & Michael A. Freitas. (2007). Mass spectrometry-based strategies for characterization of histones and their post-translational modifications. Expert Review of Proteomics. 4(2). 211–225. 37 indexed citations
20.
Ren, Chen, Liwen Zhang, Michael A. Freitas, et al.. (2005). Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. Journal of the American Society for Mass Spectrometry. 16(10). 1641–1653. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Beltrame Breakdown of academic impact, for papers by Feng Qi Breakdown of academic impact, for papers by Nassim Ghaffari‐Tabrizi‐Wizsy Breakdown of academic impact, for papers by Douglas C. Marchion Breakdown of academic impact, for papers by Weiwei Li Breakdown of academic impact, for papers by Lingling Liu Breakdown of academic impact, for papers by Kyunggon Kim Breakdown of academic impact, for papers by Hideto Senzaki
Rankless by CCL
2026